Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa C Southey

Showing results (1-10 of 574) with videos related to

Pageof 58
Sort By:
The Medical Journal of Australia|March 18, 2016
Gene panel testing for hereditary breast cancerIngrid Winship, Melissa C Southey
Trends in Cancer|March 27, 2020
PALB2 Genetic Variants: Can Functional Assays Assist Translation?Melissa C Southey, Amanda Rewse, Tu Nguyen-Dumont
Hereditary Cancer in Clinical Practice|April 22, 2016
PALB2: research reaching to clinical outcomes for women with breast cancerMelissa C Southey, Ingrid Winship, Tú Nguyen-Dumont
The Application of Clinical Genetics|August 13, 2013
PALB2 and breast cancer: ready for clinical translation!Melissa C Southey, Zhi L Teo, Ingrid Winship
Breast Cancer Research : BCR|June 19, 2008
Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?Graham B Byrnes, Melissa C Southey, John L Hopper
British Journal of Cancer|February 19, 2020
Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancerEe Ming Wong, Melissa C Southey, Mary Beth Terry
Clinical Epigenetics|July 3, 2025
A review of the use of tumour DNA methylation for breast cancer subtyping and prediction of outcomesElaheh Zarean, Shuai Li, Melissa C Southey, et al.
Cancer Medicine|November 12, 2024
Epigenetic Ageing and Breast Cancer Risk: A Systematic ReviewEmily McLennan, Danmeng Lily Li, Melissa C Southey, et al.
Current Oncology Reports|April 14, 2007
Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancerMark A Jenkins, Melissa C Southey, Graham G Giles, et al.
Breast Cancer Research and Treatment|June 1, 2010
No evidence of MMTV-like env sequences in specimens from the Australian Breast Cancer Family StudyDaniel J Park, Melissa C Southey, Graham G Giles, et al.
Pageof 58

Showing results (1-10 of 574) with videos related to

Sort By:
Pageof 58
The Medical Journal of Australia|March 18, 2016
Gene panel testing for hereditary breast cancerIngrid Winship, Melissa C Southey
Trends in Cancer|March 27, 2020
PALB2 Genetic Variants: Can Functional Assays Assist Translation?Melissa C Southey, Amanda Rewse, Tu Nguyen-Dumont
Hereditary Cancer in Clinical Practice|April 22, 2016
PALB2: research reaching to clinical outcomes for women with breast cancerMelissa C Southey, Ingrid Winship, Tú Nguyen-Dumont
The Application of Clinical Genetics|August 13, 2013
PALB2 and breast cancer: ready for clinical translation!Melissa C Southey, Zhi L Teo, Ingrid Winship
Breast Cancer Research : BCR|June 19, 2008
Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?Graham B Byrnes, Melissa C Southey, John L Hopper
British Journal of Cancer|February 19, 2020
Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancerEe Ming Wong, Melissa C Southey, Mary Beth Terry
Clinical Epigenetics|July 3, 2025
A review of the use of tumour DNA methylation for breast cancer subtyping and prediction of outcomesElaheh Zarean, Shuai Li, Melissa C Southey, et al.
Cancer Medicine|November 12, 2024
Epigenetic Ageing and Breast Cancer Risk: A Systematic ReviewEmily McLennan, Danmeng Lily Li, Melissa C Southey, et al.
Current Oncology Reports|April 14, 2007
Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancerMark A Jenkins, Melissa C Southey, Graham G Giles, et al.
Breast Cancer Research and Treatment|June 1, 2010
No evidence of MMTV-like env sequences in specimens from the Australian Breast Cancer Family StudyDaniel J Park, Melissa C Southey, Graham G Giles, et al.
Pageof 58